AbbVie Inc. — Director's Dealing 2024

Jul 19, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2024-07-17

Reporting Person: GONZALEZ RICHARD A (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-07-17	Common Stock, $0.01 par value	M	87050	$61.36	Acquired	600149	Direct
2024-07-17	Common Stock, $0.01 par value	M	119418	$79.02	Acquired	719567	Direct
2024-07-17	Common Stock, $0.01 par value	M	76377	$93.5	Acquired	795944	Direct
2024-07-17	Common Stock, $0.01 par value	S	282845	$175	Disposed	513099	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-07-17	Option (Right To Buy)	$61.36	M	87050	Disposed	2027-02-15	Common Stock (87050)	Direct
2024-07-17	Option (Right To Buy)	$79.02	M	119418	Disposed	2029-02-20	Common Stock (119418)	Direct
2024-07-17	Option (Right To Buy)	$93.5	M	76377	Disposed	2030-02-19	Common Stock (76377)	Direct

Footnotes

F1: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.